Neuronetics (STIM) Assets Average (2018 - 2026)
Neuronetics' (STIM) quarterly Assets Average came in at $133.5 million in Q1 2026, down 5.62% year-on-year from $141.4 million in Q1 2025, and down 6.98% on a QoQ basis from $143.5 million in Q4 2025.
Neuronetics (STIM) Assets Average (2018 - 2026) Analysis & Trends
Neuronetics (STIM) has 9 years of Assets Average data on file, last reported at $133.5 million in Q1 2026.
- On a quarterly basis, Assets Average fell 5.62% year-over-year to $133.5 million in Q1 2026; TTM through Mar 2026 was $133.5 million, a 5.62% decrease from a year earlier, with the FY2025 full-year figure at $141.2 million, up 10.02% from the prior year.
- Assets Average for Q1 2026 stood at $133.5 million, down from $143.5 million in the prior quarter.
- Over the last five years, Assets Average for STIM reached as high as $143.5 million in Q4 2025 and fell as low as $85.5 million in Q3 2024.
- Historically, Assets Average has averaged $118.5 million across 5 years, with a median of $118.1 million in 2022.
- Across the five-year window, Assets Average fell 20.15% in 2023 and surged 63.88% in 2025, its largest moves.
- Year by year, Assets Average stood at $118.1 million in 2022, then dropped by 11.56% to $104.4 million in 2023, then advanced by 2.97% to $107.5 million in 2024, then soared by 33.48% to $143.5 million in 2025, then slipped by 6.98% to $133.5 million in 2026.
- Per Business Quant data, the three most recent Assets Average figures were $133.5 million in Q1 2026, $143.5 million in Q4 2025, and $140.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 98.57 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 47.07 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 92.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.01 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 13.51 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 6.49 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 31.64 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 37.02 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 10.57 Bn |
| 10 | Neuronetics | 130.83 Mn | 128.62 Mn | 16.15 Mn | 133.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 133.50 Mn |
| Dec 31, 2025 | 143.51 Mn |
| Sep 30, 2025 | 140.06 Mn |
| Jun 30, 2025 | 138.32 Mn |
| Mar 31, 2025 | 141.45 Mn |
| Dec 31, 2024 | 107.51 Mn |
| Sep 30, 2024 | 85.47 Mn |
| Jun 30, 2024 | 100.31 Mn |
| Mar 31, 2024 | 109.82 Mn |
| Dec 31, 2023 | 104.41 Mn |
| Sep 30, 2023 | 96.69 Mn |
| Jun 30, 2023 | 102.00 Mn |
| Mar 31, 2023 | 110.24 Mn |
| Dec 31, 2022 | 118.06 Mn |
| Sep 30, 2022 | 121.09 Mn |
| Jun 30, 2022 | 126.45 Mn |
| Mar 31, 2022 | 135.58 Mn |
| Dec 31, 2021 | 142.15 Mn |
| Sep 30, 2021 | 145.58 Mn |
| Jun 30, 2021 | 150.20 Mn |